Nalbix (Clotrimazole)

Clotrimazole is an azole antifungal that acts on Candida species causing vaginal infections.

• Vaginal candidiasis: eliminates yeast overgrowth, relieving itching, discharge, and irritation.
• Recurrent vulvovaginal candidiasis: reduces the frequency of episodes when used as maintenance therapy.
• Mixed vaginal infections: helps control the Candida component in polymicrobial infections.

• Clotrimazole inhibits the fungal enzyme lanosterol 14α‑demethylase, a key step in ergosterol synthesis. By blocking this pathway, the drug disrupts the fungal cell membrane, increasing permeability and leading to cell death. The selective inhibition targets Candida species while sparing human cells, providing effective antifungal activity at the site of application.

Clotrimazole may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects

• Burning sensation: mild burning at the site of application.
• Vaginal itching: transient itching after insertion.
• Discharge: increased vaginal discharge or spotting.
• Irritation: mild irritation or redness of the vaginal mucosa.

Serious or Rare Side Effects

• Allergic reaction: rash, swelling, or hives indicating hypersensitivity.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Hepatic dysfunction: rare liver enzyme elevations.

Before using Nalbix, consider the following safety measures.

• Pregnancy: consult a healthcare professional before use.
• Breastfeeding: discuss potential risks with a physician.
• Allergy: avoid if known hypersensitivity to clotrimazole or other azoles.
• Concurrent vaginal products: do not use other intravaginal medications simultaneously without advice.
• Immunocompromised patients: use with caution and monitor response.
• Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Clotrimazole can interact with other medicines; awareness helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Systemic azole antifungals (e.g., fluconazole): may increase systemic exposure.
• CYP3A4 inhibitors (e.g., ketoconazole): can raise local clotrimazole levels.
• Hormonal contraceptives: potential reduction in efficacy, though evidence is limited.

Moderate Interactions (Monitor Closely)

• Topical steroids: may diminish antifungal effect.
• Antibiotics altering vaginal flora: could affect treatment outcome.
• Other intravaginal medications: monitor for irritation or reduced absorption.